Nucleix Company

Nucleix develops, manufactures, and markets non-invasive molecular cancer diagnostic tests.
Technology: Biomarker Pannel
Industry: Longevity Biomarkers
Headquarters: Rehovot, HaMerkaz, Israel
Founded Date: 2008-01-01
Employees Number: 11-50
Funding Status: Seed
Investors Number: 13
Total Funding: 82986064
Estimated Revenue: $10M to $50M
Last Funding Date: 2022-01-05
Last Funding Type: Venture - Series Unknown

Visit Website
Register and Claim Ownership